Scientists hunt for hidden HIV markers in treated patients
NCT ID NCT03940521
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involves 48 adults with HIV who have had undetectable virus levels for at least 2 years while on antiretroviral therapy. Researchers are measuring two specific markers (CD32a and X) on immune cells to see if they relate to the amount of hidden HIV DNA in the body. The goal is to better understand where HIV hides, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nimes
Nîmes, 30029, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single HIV pill tame the epidemic in africa?
- Could a shorter drug course beat a longer one for a deadly fungal infection?
- A kinder, more personal touch may help people with HIV stay in care — a large trial in zambia puts it to the test
- Can tracking HIV's genetic fingerprints reveal where the epidemic is heading?
- Can a new drug, GS-0415, help keep HIV in check? a First-in-Human trial aims to find out
- Could a shot replace daily HIV pills? new trial tests injectable combo